Market watch: Biopharma deal-making in 2014: a record year for M&A value

Affiliations

Amanda Micklus et al. Nat Rev Drug Discov. 2015 Feb.

. 2015 Feb;14(2):84-5.

doi: 10.1038/nrd4536.

No abstract available

Similar articles

Biotech jostles with pharma for slice of HIV market.
Katsnelson A. Katsnelson A. Nat Biotechnol. 2006 Jan;24(1):3-4. doi: 10.1038/nbt0106-3. Nat Biotechnol. 2006. PMID: 16404375 No abstract available.
Deal watch: is deal-making becoming more difficult?
Borshell N. Borshell N. Nat Rev Drug Discov. 2011 Jun;10(6):404. doi: 10.1038/nrd3464. Nat Rev Drug Discov. 2011. PMID: 21629282 No abstract available.
Biopharma deal-making in 2016.
Micklus A, Muntner S. Micklus A, et al. Nat Rev Drug Discov. 2017 Mar;16(3):161-162. doi: 10.1038/nrd.2017.15. Epub 2017 Feb 17. Nat Rev Drug Discov. 2017. PMID: 28209988 No abstract available.
How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Perakslis ED, Van Dam J, Szalma S. Perakslis ED, et al. Clin Pharmacol Ther. 2010 May;87(5):614-6. doi: 10.1038/clpt.2010.21. Epub 2010 Apr 7. Clin Pharmacol Ther. 2010. PMID: 20376001 Review. No abstract available.
The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.
Woosley RL, Myers RT, Goodsaid F. Woosley RL, et al. Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27. Clin Pharmacol Ther. 2010. PMID: 20407457 Review.